Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-26

Clinical Trial Update: Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring [NA]

View source ↗

Summary

An clinical trial comparing self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM) in Type 2 diabetes has completed, featuring a modal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HealthPartners Institute | Conditions: Type 2 Diabetes | NA | Status: COMPLETED